
Challenges of developing novel therapies for bronchopulmonary dysplasia-associated pulmonary hypertension
13 November 2025
A PVRI Digital Webinar
This webinar is part of the 'Cutting Edge Innovation in Clinical & Experimental PH’ sessions, which takes place bi-monthly on the second Thursday at 16:00 GMT/BST. Each session features keynote talks and discussion from senior experts in the field as well as young and mid-level investigators.
The PVRI Digital Webinar Series is open to everyone to attend and we encourage active audience participation.
13 November, 4pm GMT
Presentations
- A brief introduction to clinical features of PH in BPD Steve Abman, University of Colorado
- BPD-associated PH: Current evaluation and therapies Anne Hilgendorff, Carl von Ossietzky University Oldenburg
- BPD-PH: Understudied and undertreated- the need for novel interventions Bernard Thebaud, Ottawa Hospital Research Institute
- Challenges in designing and implementing multicenter trials: A real world perspective on studies of preterm infants Victoria Niklas, Oak Hills Bio
Moderated by Steve Abman, University of Colorado, and Sylvia Nikkho, Bayer AG.
Speakers & moderators
Steve Abman, University of Colorado, USA
Anne Hilgendorff, Carl von Ossietzky University Oldenburg, Germany
Bernard Thebaud, Ottawa Hospital Research Institute, Canada
Victoria Niklas, Oak Hills Bio, USA
Sylvia Nikkho, Bayer AG, Germany